Opinion | The Lady and the Trump

WASHINGTON — I’ve been riveted all week by the spectacle of the most famous blond phenom on the planet, a child isolated and miserable living inside a national landmark, lashing out and spiraling into self-destructive acts.

But eventually I had to turn off the new season of “The Crown,” focusing on Princess Diana, and drag my attention back to Donald Trump, who is trashing this place before checking out like he’s Axl Rose at a Four Seasons.

Diana and Donald shared a few things in common: their toxic tango with the press, their psychic connection with their fan base, their willingness to blow up norms. They were both “unpredictable meteors,” as Tony Blair once described Di. They both savored sitting in their rooms glued to their own coverage on TV, dialing up their chosen reporters to control the narrative. They were both unhappy at the top, fretting about being undercut.

Read More

EyePoint Pharmaceuticals to Host Key Opinion Leader Virtual Roundtable on the Future of Drug …

WATERTOWN, Mass., Nov. 19, 2020 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced it will host a key opinion leader roundtable discussion on the future of local drug delivery for wet aged-related macular degeneration (AMD) and an overview of EYP-1901, the Company’s potential six-month sustained delivery intravitreal anti-VEGF therapy for wet AMD. The event will take place virtually on Friday, December 4, 2020, at 12:00 p.m. ET.

Scheduled to participate in the event are several leading retina specialists, including Robert Avery, M.D., Founder and Chief Executive Officer, California Retina Consultants; Elias Reichel, M.D., Professor and Vice Chair, Director, Vitreoretinal Service, New England Eye Center, Tufts University of Medicine; and Charles Wykoff, M.D., Ph.D., Director of Research, Retina Consultants of Houston, Deputy Chair For Ophthalmology, Blanton Eye Institute.

To access the event, please dial (877) 870-4263 from the

Read More

Opinion | So, Did ‘Bad Things Happen’ With the Election in Philadelphia?

Joe Biden’s lead in the presidential election results in Pennsylvania has now surpassed 81,000 votes, far exceeding Donald Trump’s 44,000-vote victory margin there four years ago. Yet the Trump campaign continues to claim in court huge but incalculable levels of fraud, particularly in Philadelphia.

As with cases filed elsewhere around the country, Mr. Trump will not succeed. Even a cursory examination of the data refutes any notion of substantial voting fraud.

As a threshold matter, it is important to understand how eerily similar the 2020 results in Philadelphia were to 2016. As of Tuesday evening, 743,966 votes for president had been counted in Philadelphia — an increase of 34,348 votes from 2016. This 4.8 percent increase in turnout is less than half of the 11.6 percent increase in turnout seen in the state as a whole.

Not only was the increase in the number of ballots cast in Philadelphia from

Read More

Opinion | The Latest Vaccine News Doesn’t Tell the Full Story

This article is part of the Debatable newsletter. You can sign up here to receive it on Tuesdays and Thursdays.

The drugmakers Moderna and Pfizer buoyed hopes for an end to the coronavirus pandemic when they announced this month that their vaccines were 94.5 percent (Moderna) and 90 percent (Pfizer) effective at preventing Covid-19, based on preliminary results from ongoing clinical trials. Neither vaccine produced any serious safety concerns.

Pfizer’s and Moderna’s data were analyzed by independent experts, though their findings were published in news releases, not peer-reviewed scientific journals, so the results are not yet considered conclusive. But if the numbers hold steady through the end of the trials, these vaccines would be among some of the most effective ever created.

What would that mean for the future of the pandemic and vaccine science, and what obstacles still stand in the way of getting shots in people’s arms? Here’s

Read More

Opinion | Tech platforms need to be checked. Instead, Congress gives us theater.

Incidentally, so does Congress.

Facebook’s Mark Zuckerberg and Twitter’s Jack Dorsey went virtually to Washington this week to talk about Section 230 of the Communications Decency Act, the provision that protects platforms like theirs from liability for most of what their users post. This sounds awfully technical, and it is — but that’s mostly irrelevant, because lawmakers these days display little interest in making law. They are much more interested in making theater. The odd couple called to testify this week aren’t so much guest stars as they are props in an elaborate and never-ending performance art that’s starting to get old.

Zuckerberg was summoned for his first flagellation in 2018 following the Cambridge Analytica imbroglio. A chorus of 100 lawmakers assembled to fire nearly 600 queries at him over the course of 10 hours. His testimony offered nary a novel insight and nary a scandalous slip-up, but no one

Read More

Opinion | Why the 2020 Election Makes It Hard to be Optimistic About the Future

The 2020 election is over. And the big winners were the coronavirus and, quite possibly, catastrophic climate change.

OK, democracy also won, at least for now. By defeating Donald Trump, Joe Biden pulled us back from the brink of authoritarian rule.

But Trump paid less of a penalty than expected for his deadly failure to deal with Covid-19, and few down-ballot Republicans seem to have paid any penalty at all. As a headline in The Washington Post put it, “With pandemic raging, Republicans say election results validate their approach.”

And their approach, in case you missed it, has been denial and a refusal to take even the most basic, low-cost precautions — like requiring that people wear masks in public.

The epidemiological consequences of this cynical irresponsibility will be ghastly. I’m not sure how many people realize just how terrible this winter is going to be.

Deaths from Covid-19 tend

Read More

Opinion | At-Home Covid Tests and Other Powers of a Tech Billionaire



Chamath Palihapitiya is one of Silicon Valley’s most successful tech investors. He’s also among the most candid. “I aspire to be a Koch brother before I aspire to be an under secretary,” he tells Kara Swisher on this episode of “Sway.” His definition of power has little to do with politics — it’s profits, he says, that empower you to “control the resources.”

Mr. Palihapitiya made his first fortune as an early executive at Facebook. He has since multiplied his wealth as an investor, with big bets and bold forecasts about the future. These days, he’s behind one of the most lucrative and controversial trends — SPACs, the acronym for blank check or special purpose acquisition companies, which some call the next bubble.

On this episode of “Sway,” Mr. Palihapitiya shares his predictions for American economic recovery

Read More

Opinion: Nuclear technology will be a key piece of Canada’s energy future

General view of the Pickering Nuclear Power Generating Station, April 17, 2019.

CARLOS OSORIO/Reuters

John Gorman is the president and CEO of the Canadian Nuclear Association.

Undisputedly, nuclear must be in the energy mix for Canada to reach its greenhouse gas emissions reductions targets. Minister of Natural Resources Seamus O’Regan recently said as much when he stated that the federal government has “not seen a credible model where we can get to net-zero emissions by 2050 without nuclear.”

It’s about time. Nuclear power is a clean energy. It does not emit carbon or pollutants that harm human health and the environment, and it’s the only energy source that delivers carbon-free, reliable heat and electricity around the clock. As a result, new nuclear – specifically, small modular reactors (SMRs) – are uniquely positioned to decarbonize our extraction industries, provide heat and power to First Nations communities, and work in tandem with

Read More

Opinion | The Danger in White Moderates Setting Biden’s Agenda

The stakes for all of us are high.

With the coronavirus entering what some scientists say could be its deadliest wave yet, all of our social institutions are buckling under the stress. This pandemic did not only unleash a nimble biological threat to public health, it also politicized common-sense public health measures.

We do not have the testing strategy that every reputable scientist tells us we will need to return to merely normal political sectarianism. The right lost faith in science when science resisted racist declarations. The left lost faith in scientists when the right turned them into political pawns. We cannot even trust the Centers for Disease Control and Prevention, whose missteps in providing good guidance to the public reinforced conspiracy theories and eased the way for its delegitimization by this administration.

The Trump administration carried out that delegitimization primarily as a shield for the president’s outright corruption and

Read More

Opinion: America’s standing in the world took a big hit on election night

Presented with an opportunity for a wholesale rejection of a highly divisive, race-baiting, xenophobic, media-hating, anti-science, lying, juvenile incumbent, a sizable swath of America’s voters decided to take a pass and pull the lever for Donald Trump, and that speaks volumes about who we are as a nation.

But all this didn’t happen in a vacuum; the world has been watching.

Joe Biden may still end up winning this election, but no matter how you cut it, it was clear here and around the globe that roughly half of America believes that the character of our President doesn’t matter all that much, an impeachment is meaningless and the Department of Justice really should serve as the chief executive’s personal law firm.

More importantly, from a global perspective, roughly one in two of American voters signaled to the world that not only are capricious trade wars palatable, but long-standing global alliances

Read More